Fig. 4From: Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosisCumulative HCC incidence in different risk groups. Patients were stratified by the 25th and 75th percentiles of the HCC risk score (< 95.45, 95.45–124.76, > 124.76 points)Back to article page